Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma.

Details

Language :

English

ISSN :

0732183X

Volume :

32

Issue :

11

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

95380727

Full Text :

https://doi.org/10.1200/JCO.2013.52.0924